No credible reports or official statements have linked the 2026 Andes virus outbreak on the MV Hondius cruise ship to any laboratory incident, driving near-unanimous trader consensus against confirmation by June 30. Investigations by the WHO and CDC trace cases to zoonotic spillover or rare person-to-person transmission, consistent with the virus's established South American rodent reservoir and the index patient's exposure in Argentina. Limited case counts, transparent public health updates, and absence of whistleblower claims or genomic anomalies pointing to lab manipulation reinforce the market's 99.7% implied probability for "No." A realistic upset would require an unprecedented last-minute revelation—such as verified evidence of gain-of-function research or a concealed incident—within the next 12 days, an outcome historical patterns and current data render highly improbable.